Naomi Williams
Family · Universal City, TXNPI 1144008491
Payments from drug & device makers
Across 138 payments — averaging $31.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Seagen Inc.$452
- Daiichi Sankyo Inc.$400
- AstraZeneca$314
- Lilly USA, LLC$288
- Merck$282
- Genentech USA, Inc.$274
- plus $2K from 31 others
What the payments were for
- Food & beverage$3,83687%
- Education$56413%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Seagen Inc. | 6 | $452 |
| Daiichi Sankyo Inc. | 10 | $400 |
| AstraZeneca(2 entities) | 14 | $314 |
| Lilly USA, LLC | 7 | $288 |
| Merck | 13 | $282 |
| Genentech USA, Inc. | 5 | $274 |
| Regeneron Healthcare Solutions, Inc. | 3 | $273 |
| Johnson & Johnson | 3 | $246 |
| Eisai Inc. | 8 | $177 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $165 |
| Novartis | 7 | $150 |
| Bayer | 5 | $125 |
| Tempus AI, Inc | 1 | $114 |
| E.r. Squibb & Sons, L.L.C. | 1 | $112 |
| Incyte Corporation | 5 | $109 |
| Ipsen Biopharmaceuticals, Inc | 5 | $99 |
| AbbVie | 4 | $87 |
| Sumitomo Pharma America, Inc. | 3 | $78 |
| Immunocore Limited | 2 | $57 |
| Karyopharm Therapeutics Inc. | 3 | $57 |
| Deciphera Pharmaceuticals Inc. | 2 | $55 |
| Morphosys, US Inc. | 2 | $49 |
| Pfizer | 2 | $49 |
| Sanofi | 2 | $45 |
| Spectrum Pharmaceuticals Inc. | 2 | $43 |
| Stemline Therapeutics Inc. | 2 | $42 |
| EMD Serono, Inc. | 2 | $38 |
| Servier Pharmaceuticals LLC | 2 | $37 |
| Jazz Pharmaceuticals Inc. | 2 | $32 |
| Taiho Oncology, Inc. | 1 | $29 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $24 |
| Sobi, Inc | 1 | $23 |
| Recordati_rare_diseases_inc. | 1 | $20 |
| ADC Therapeutics America, Inc. | 1 | $16 |
| Rigel Pharmaceuticals, Inc. | 1 | $15 |
| Exelixis Inc. | 1 | $15 |
| Blueprint Medicines Corporation | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,401 in reported general payments places this provider in the 90th percentile of 15,456 family providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prochlorperazine Maleate | 15 | $606 |
| Ondansetron OdtOndansetron | 15 | $378 |
| Triamcinolone Acetonide | 14 | $213 |
| Duloxetine Hcl | 11 | $163 |
| Lidocaine-PrilocaineLidocaine/Prilocaine | 11 | $128 |
Paid to pharmacies, not to this prescriber.
Other family in Universal City
- Lashonda CraneHouston$3.4M
- David WeirDallas$959K
- Luba YammineHouston$479K
- Robin BeachHouston$428K
- Nirupama JeromeAustin$418K
- April LopezMcAllen$417K
- Linda MercadoHouston$211K
- Sarah AguilarHouston$199K
- Sie ThomasDallas$197K
- Anna CastroSan Antonio$184K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.